Cannabinoid receptors undergo axonal flow in sensory nerves

Neuroscience

Volumn 92, Issue 4, 1999, Pages 1171-1175

  Hohmann, A G ^a   Herkenham, M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Anandamide; Anterograde transport; Dorsal root ganglia; Neurosecretion; Peripheral

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; AXOPLASM FLOW; CONTROLLED STUDY; GENE EXPRESSION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; NERVE FIBER TRANSPORT; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SCIATIC NERVE; SENSORY NERVE; SPINAL GANGLION; SPLEEN;

ANIMALS; AUTORADIOGRAPHY; AXONAL TRANSPORT; CYCLOHEXANOLS; GANGLIA, SPINAL; IN SITU HYBRIDIZATION; MALE; NEURONS, AFFERENT; PERIPHERAL NERVES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; SCIATIC NERVE;

EID: 0033016805     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00220-1     Document Type: Article

References (35)

1. Calignano A., La Rana G., Giuffrida A., Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 394:1998;277-281.
2. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S.D., Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. natn. Acad. Sci. U.S.A. 92:1995;3376-3380.
3. Felder C.C., Joyce K.E., Briley E.M., Mansouri J., Mackie K., Blond O., Lai Y., Ma A.L., Mitchell R.L. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Molec. Pharmac. 48:1995;443-450.
4. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
5. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. natn. Acad. Sci. U.S.A. 87:1990;1932-1936.
6. Hohmann A.G., Briley E.M., Herkenham M. Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Res. 822:1999;17-25.
7. Hohmann A.G., Herkenham M. Regulation of cannabinoid and mu opioid receptor binding sites following neonatal capsaicin treatment. Neurosci. Lett. 252:1998;13-16.
8. Hohmann A.G., Herkenham M. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience. 90:1999;923-931.
9. Hohmann A.G., Martin W.J., Tsou K., Walker J.M. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. Life Sci. 56:1995;2111-2118.
10. Hohmann A.G., Tsou K., Walker J.M. Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2. Neurosci. Lett. 257:1998;119-122.
11. Hohmann A.G., Tsou K., Walker J.M. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. J. Neurophysiol. 81:1999;575-583.
12. 2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain. 76:1998;189-199.
13. Li J., Daughters R.S., Bengiamin R., Simone D.A. Intraplantar injection of the cannabinoid receptor agonist CP 55,940 attenuates capsaicin-evoked nocifensive behavior and hyperalgesia in rats. Soc. Neurosci. Abstr. 24:1998;1628.
14. Lichtman A.H., Martin B.R. Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmac. exp. Ther. 258:1991;517-523.
15. Liu H., Wang H., Sheng M., Jan L.Y., Jan Y.N., Basbaum A.I. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc. natn. Acad. Sci. U.S.A. 91:1994;8383-8387.
16. Martin W.J., Hohmann A.G., Walker J.M. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects. J. Neurosci. 16:1996;6601-6611.
17. Martin W.J., Tsou K., Walker J.M. Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci. Lett. 242:1998;33-36.
18. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
19. McLean S. Axonal transport of opiate receptor subtypes. Peptides. 9:1988;85-89.
20. Meng I.D., Manning B.H., Martin W.J., Fields H.L. An analgesia circuit activated by cannabinoids. Nature. 395:1998;381-384.
21. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
22. Richardson J.D., Aanonsen L., Hargreaves K.M. Antihyperalgesic effects of spinal cannabinoids. Eur. J. Pharmac. 345:1998;145-153.
23. Richardson J.D., Aanonsen L., Hargreaves K.M. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J. Neurosci. 18:1998;451-457.
24. 1 receptors. Pain. 75:1998;111-119.
25. 9-tetrahydrocannabinol-induced analgesia. Brain Res. 578:1992;8-12.
26. Strangman N.M., Patrick S.L., Hohmann A.G., Tsou K., Walker J.M. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res. 813:1998;323-328.
27. Strangman N. M. and Walker J. M. (1999) The cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses. J. Neurophysiol. (in press).
28. Tonra J.R., Curtis R., Wong V., Cliffer K.D., Park J.S., Timmes A., Nguyen T., Lindsay R.M., Acheson A., DiStefano P.S. Axotomy upregulates the anterograde transport and expression of brain-derived neurotrophic factor by sensory neurons. J. Neurosci. 18:1998;4374-4383.
29. Tsou K., Brown S., Sanudo-Peña M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 83:1998;393-411.
30. Tsou K., Lowitz K.A., Hohmann A.G., Martin W.J., Hathaway C.B., Bereiter D.A., Walker J.M. Suppression of noxious stimulus-evoked expression of FOS protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience. 70:1996;791-798.
31. Welch S.P., Stevens D.L. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J. Pharmac. exp. Ther. 262:1992;10-18.
32. Whitfield H.J. Jr., Brady L.S., Smith M.A., Mamalaki E., Fox R.J., Herkenham M. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol. Cell. molec. Neurobiol. 10:1990;145-157.
33. Yaksh T.L. The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat. J. clin. Pharmac. 21:1981;334S-340S.
34. 3H]opioid receptors in rat brain. Brain Res. 179:1979;255-270.
35. Young W.S. III, Wamsley J.K., Zarbin M.A., Kuhar M.J. Opioid receptors undergo axonal flow. Science. 210:1980;76-78.